856 related articles for article (PubMed ID: 33063247)
1. Novel Analgesics with Peripheral Targets.
Ciotu CI; Fischer MJM
Neurotherapeutics; 2020 Jul; 17(3):784-825. PubMed ID: 33063247
[TBL] [Abstract][Full Text] [Related]
2. Opioids and sensory nerves.
Stein C; Zöllner C
Handb Exp Pharmacol; 2009; (194):495-518. PubMed ID: 19655116
[TBL] [Abstract][Full Text] [Related]
3. Novel strategies for the treatment of inflammatory hyperalgesia.
Chopade AR; Mulla WA
Eur J Clin Pharmacol; 2010 May; 66(5):429-44. PubMed ID: 20155257
[TBL] [Abstract][Full Text] [Related]
4. TRPV4: new therapeutic target for inflammatory bowel diseases.
Vergnolle N
Biochem Pharmacol; 2014 May; 89(2):157-61. PubMed ID: 24440740
[TBL] [Abstract][Full Text] [Related]
5. Targeting cell surface trafficking of pain-facilitating receptors to treat chronic pain conditions.
Ma W; Quirion R
Expert Opin Ther Targets; 2014 Apr; 18(4):459-72. PubMed ID: 24512266
[TBL] [Abstract][Full Text] [Related]
6. Novel Targets and Drug Delivery System in the Treatment of Postoperative Pain: Recent Studies and Clinical Advancement.
Satapathy T; Singh G; Pandey RK; Shukla SS; Bhardwaj SK; Gidwani B
Curr Drug Targets; 2024; 25(1):25-45. PubMed ID: 38037995
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide, is it a promise analgesic drug or another inflammatory pain mediator?
Cunha TM; Verri WA
Pain; 2007 Aug; 130(3):300-302. PubMed ID: 17553618
[No Abstract] [Full Text] [Related]
8. Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential.
Meng J; Ovsepian SV; Wang J; Pickering M; Sasse A; Aoki KR; Lawrence GW; Dolly JO
J Neurosci; 2009 Apr; 29(15):4981-92. PubMed ID: 19369567
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and chemokine regulation of sensory neuron function.
Miller RJ; Jung H; Bhangoo SK; White FA
Handb Exp Pharmacol; 2009; (194):417-49. PubMed ID: 19655114
[TBL] [Abstract][Full Text] [Related]
10. Central Nervous System Targets: Supraspinal Mechanisms of Analgesia.
Bannister K; Dickenson AH
Neurotherapeutics; 2020 Jul; 17(3):839-845. PubMed ID: 32700132
[TBL] [Abstract][Full Text] [Related]
11. IL-1 as a target in inflammation.
Ito Y; Kaneko N; Iwasaki T; Morikawa S; Kaneko K; Masumoto J
Endocr Metab Immune Disord Drug Targets; 2015; 15(3):206-11. PubMed ID: 26333726
[TBL] [Abstract][Full Text] [Related]
12. Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities.
Fu WY; Wang X; Ip NY
ACS Chem Neurosci; 2019 Feb; 10(2):872-879. PubMed ID: 30221933
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
14. Sensory-nerve-derived neuropeptides: possible therapeutic targets.
Fernandes ES; Schmidhuber SM; Brain SD
Handb Exp Pharmacol; 2009; (194):393-416. PubMed ID: 19655113
[TBL] [Abstract][Full Text] [Related]
15. Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
Chen R; Coppes OJM; Urman RD
Pain Physician; 2021 Mar; 24(2):153-163. PubMed ID: 33740349
[TBL] [Abstract][Full Text] [Related]
16. CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.
Vellani V; Sabatini C; Milia C; Caselli G; Lanza M; Letari O; Rovati LC; Giacomoni C
Br J Pharmacol; 2020 Jan; 177(1):48-64. PubMed ID: 31454418
[TBL] [Abstract][Full Text] [Related]
17. Positioning dual inhibitors in the treatment of pain and inflammatory disorders.
Kulkarni SK; Singh VP
Inflammopharmacology; 2008 Feb; 16(1):1-15. PubMed ID: 18256800
[No Abstract] [Full Text] [Related]
18. Discovery of novel limonin derivatives as potent anti-inflammatory and analgesic agents.
Wang SC; Yang Y; Liu J; Jiang AD; Chu ZX; Chen SY; Gong GQ; He GW; Xu YG; Zhu QH
Chin J Nat Med; 2018 Mar; 16(3):231-240. PubMed ID: 29576060
[TBL] [Abstract][Full Text] [Related]
19. TRP channel antagonists for pain--opportunities beyond TRPV1.
Bevan S; Andersson DA
Curr Opin Investig Drugs; 2009 Jul; 10(7):655-63. PubMed ID: 19579171
[TBL] [Abstract][Full Text] [Related]
20. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential.
Lambert DG
Nat Rev Drug Discov; 2008 Aug; 7(8):694-710. PubMed ID: 18670432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
